Comment
. 2010 Sep;177(3):1573-4; author reply 1574.
doi: 10.2353/ajpath.2010.100484.
Epub 2010 Jul 22.
Cimetidine as an organic cation transporter antagonist
- PMID: 20651231
- PMCID: PMC2928986
- DOI: 10.2353/ajpath.2010.100484
Item in Clipboard
Comment
Cimetidine as an organic cation transporter antagonist
Am J Pathol.
2010 Sep.
Abstract
This Correspondence relates to “Organic transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions” (Am J Pathol 2010, 176:1169–1180).
Comment on
-
Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions.Am J Pathol. 2010 Mar;176(3):1169-80. doi: 10.2353/ajpath.2010.090610. Epub 2010 Jan 28. Am J Pathol. 2010. PMID: 20110413 Free PMC article.
Similar articles
-
Effect of cimetidine, a model drug for inhibition of the organic cation transport (OCT2/MATE1) in the kidney, on the pharmacokinetics of glycopyrronium.Int J Clin Pharmacol Ther. 2013 Oct;51(10):771-9. doi: 10.5414/CP201946. Int J Clin Pharmacol Ther. 2013. PMID: 24040847 Clinical Trial.
-
Altered pharmacokinetics of cimetidine caused by down-regulation of renal rat organic cation transporter 2 (rOCT2) after liver ischemia-reperfusion injury.Drug Metab Pharmacokinet. 2013;28(6):504-9. doi: 10.2133/dmpk.dmpk-13-rg-021. Epub 2013 Jun 18. Drug Metab Pharmacokinet. 2013. PMID: 23774469
-
Importance of the Azole Moiety of Cimetidine Derivatives for the Inhibition of Human Multidrug and Toxin Extrusion Transporter 1 (hMATE1).Chem Pharm Bull (Tokyo). 2021;69(9):905-912. doi: 10.1248/cpb.c21-00429. Chem Pharm Bull (Tokyo). 2021. PMID: 34470955
-
Extraneuronal monoamine transporter and organic cation transporters 1 and 2: a review of transport efficiency.Handb Exp Pharmacol. 2006;(175):151-80. doi: 10.1007/3-540-29784-7_8. Handb Exp Pharmacol. 2006. PMID: 16722235 Review.
-
Molecular pharmacology of organic cation transporters in kidney.J Membr Biol. 1999 Jan 15;167(2):103-17. doi: 10.1007/s002329900475. J Membr Biol. 1999. PMID: 9916142 Review. No abstract available.
Cited by
-
Zwitterionic near infrared fluorescent agents for noninvasive real-time transcutaneous assessment of kidney function.Chem Sci. 2017 Apr 1;8(4):2652-2660. doi: 10.1039/c6sc05059j. Epub 2017 Jan 11. Chem Sci. 2017. PMID: 28553500 Free PMC article.
-
The Strange Case: The Unsymmetric Cisplatin-Based Pt(IV) Prodrug [Pt(CH3COO)Cl2(NH3)2(OH)] Exhibits Higher Cytotoxic Activity with respect to Its Symmetric Congeners due to Carrier-Mediated Cellular Uptake.Bioinorg Chem Appl. 2022 Dec 30;2022:3698391. doi: 10.1155/2022/3698391. eCollection 2022. Bioinorg Chem Appl. 2022. PMID: 36620349 Free PMC article.
-
Drugs Commonly Applied to Kidney Patients May Compromise Renal Tubular Uremic Toxins Excretion.Toxins (Basel). 2020 Jun 12;12(6):391. doi: 10.3390/toxins12060391. Toxins (Basel). 2020. PMID: 32545617 Free PMC article.
References
-
- Ciarimboli G, Deuster D, Knief A, Sperling M, Holtkamp M, Edemir B, Pavenstädt H, Lanvers-Kaminsky C, Zehnhoff-Dinnesen A, Schinke AH, Koepsell H, Jürgens H, Schlatter E. Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions. Am J Pathol. 2010;176:1–12. - PMC - PubMed
-
- Corden BJ. Reaction of platinum(II) antitumor agents with sulfhydral compounds and the implications for nephrotoxicity. Inorg Chim Acta. 1987;137:125–130.
-
- El-Khateeb M, Appleton TG, Gahan LR, Charles BG, Berners-Price SJ, Bolton A-M. Reactions of cisplatin hydrolytes with methionine, cystein, and plasma ultrafiltrate studied by a combination of HPLC and NMR techniques. J Inorg Biochem. 1999;77:13–21. - PubMed
-
- Dabrowiak JC, Goodisman J, Souid A-K. Kinetic study of the reaction of cisplatin with thiols. Drug Metab Disp. 2002;30:1378–1384. - PubMed
-
- Verschraagen M, Kedde MA, Hausheer FH, van der Vijgh WJF. The chemical reactivity of BNP7787 and its metabolite mesna with the cytostatic agent cisplatin: comparison with the nucleophiles thiosulfate, DDTC, glutathione and its disulphide GSSG. Cancer Chemother Pharmacol. 2003;51:499–504. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
